Navigation Links
Radiation therapy combo cures prostate cancer long-term

Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.

This study was conducted by the physicians at the Seattle Prostate Institute. Doctors wanted to look at the combination of seed implants and external beam radiation therapy, two different types of radiation therapy, to prolong the long-term disease cure rates for prostate cancer. Over the course of 15 years, doctors followed 232 men with early-stage prostate cancer who received a course of external beam radiation therapy followed by permanent seed implants a few weeks later. Sixty-five percent of these patients had T2b-T3 disease and the entire group had an average pre-treatment PSA of 15 ng/ml.

Seed implants, also called brachytherapy, are small radioactive pellets, each about the size of a grain of rice. The seeds are inserted into the prostate through small needles during a brief outpatient procedure. External beam radiation therapy involves a series of 25 short daily outpatient treatments, where a radiation oncologist precisely directs high energy radiation beams to kill cancer cells.

"This study is exciting because it shows that the combination of brachytherapy and external beam therapy are successful long-term at curing men of their prostate cancer," said John E. Sylvester, M.D., lead author of the study and the Director of the Seattle Prostate Institute in Seattle. "This is good news for men with prostate cancer since radiation therapy is less invasive, spares healthy tissue and helps patients return to regular activities sooner than surgery."
'"/>

Source:American Society for Therapeutic Radiology and Oncology


Page: 1

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Duke Experiments Boost Radiations Cancer-Killing Effects
3. Radiation-killed bacteria vaccine induces broad immune response in mice
4. Radiation-armed robot rapidly destroys human lung tumors
5. Radiation after surgery doubles survival time for some lung cancer patients
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Combination therapy boosts effectiveness of telomere-directed cancer cell death
8. Gene therapy converts dead bone graft to new, living tissue
9. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
10. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
11. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Radiation therapy combo cures prostate cancer long term

(Date:5/20/2015)... 20, 2015 ... announced the addition of the  "5-year ... Recognition Market"  report to their offering.  ... service analyses trends in the iris ... commercial sectors, globally. Despite hardware pricing ...
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/11/2015)... 2015  Synaptics Incorporated (NASDAQ: SYNA ), ... announced the appointment of Wajid Ali ... reporting to Rick Bergman , President and ... Officer, Kathleen Bayless , who announced her ... Ali brings extensive financial management expertise to Synaptics, ...
Breaking Biology News(10 mins):Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... Reserve University School of Medicine and Albany Medical ... in a mini symposium held today at the ... (IRA) that a blend of natural botanical products ... gene, IGF-1, which is responsible for growing human ...
... brain cancer cells, called cancer stem cells, help brain ... a "repair switch" that enables them to continue to ... found. , The researchers also identified a method that ... repair switch following radiation treatment. This finding may lead ...
... activity and metabolite profiling, we determined that this protein-whose ... a lipid signaling network that contributes to cancer," said ... member of its Skaggs Institute for Chemical Biology who ... several cancers indicates that it may be a critical ...
Cached Biology News:Gene therapy research switches off joint inflammation; switches on genetic process of joint repair 2Cancer stem cells linked to radiation resistance 2Cancer stem cells linked to radiation resistance 3Study offers innovative profile of enzyme that aids tumor growth 2
(Date:5/26/2015)... 2015 WORMS, GERMANY – May ... (NYSE: GRA) announces that its manufacturing facility in ... certification from EXCiPACT™, an independent organization that certifies ... , All three Grace facilities that produce ... silica gels have now received GMP certification, following ...
(Date:5/26/2015)... 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ) announced ... will provide an update on the progress of Sangamo,s ZFP ... company,s business strategy at 1:30pm ET on Monday, June 1, ... is being held in New York, NY ... may be accessed via a link on the Sangamo BioSciences ...
(Date:5/26/2015)... May 26, 2015 Global Stem ... announced plans for the company’s first cellular and regenerative ... by a full day, hands-on stem cell training class ... Victor Garcia Gimenez, M.D., President of Therapeutic Confrontations (CONFTERA) ... community’s increasing interest in regenerative medicine and recent advances ...
(Date:5/26/2015)... Pharmaco-Kinesis Corporation (PKC) announced today that its ... on the Beach in Santa Monica, CA ... Company,s innovative Metronomic Biofeedback Pump (MBP), a fully smart ... time to a target site of the human body ... in real-time.  ...
Breaking Biology Technology:CORRECTION: Grace European Facility Receives GMP Excipient Certification for SYLOID® FP Silica Gel 2Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 2Stem Cell Training, Inc. Announces First European Symposium on Cellular and Regenerative Medicine 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5
... SEATTLE, Oct. 19 The Infectious Disease Research,Institute ... a $252,000 grant from the M.J. Murdock Charitable ... grant will enable IDRI to assemble an equipment ... against infectious,diseases. IDRI,s mission is to research and ...
... Epeius Biotechnologies,Corporation today announced that Dr. Frederick L. ... accepted an invitation to give the lead,keynote address ... at the,Global Pharma R&D Summit 2007 to be ... 8:00 a.m., Dr. Hall will present the scientific ...
... begin after markets ... 2:00 pm PT (5:00 pm ET), IRVINE, Calif., Oct. 18 ... Motion,and Low Perfusion pulse oximetry, today announced it will release third,quarter financial ... Tuesday, October 30, 2007. A conference call to review the results ...
Cached Biology Technology:Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust 2Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust 3Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA 2Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA 3Masimo to Report Third Quarter 2007 Financial Results on October 30, 2007 2Masimo to Report Third Quarter 2007 Financial Results on October 30, 2007 3
... 293 cells were cultured in Minimum Essential Medium ... the log phase of growth. In order ... cells were fixed in acetone-methanol. The cells ... coated slide, with each wells surface specifically treated ...
Cell Culture Flask, 175 cm, tissue-culture treated polystyrene, barcoded...
... Microsphere/Microarray Stabilizer is an aqueous solution that ... non-toxic chemicals in a PBS buffer (phosphate ... This product contains a combination of 0.02% ... StabilCoat Plus Stabilizer provides optimum performance ...
... Corning CellBIND surface is produced by a ... hydrophilic surface giving more consistent, even cell ... enhances cell attachment and growth uunder difficult ... • CellBIND may provide a more ecominic ...
Biology Products: